Veeva Systems Inc Class A

Veeva Systems Inc Class A

Yahoo Finance • yesterday

1 momentum stock to keep an eye on and 2 that underwhelm

1 momentum stock to keep an eye on and 2 that underwhelm The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or i... Full story

Yahoo Finance • 6 days ago

AI CRM Adoption Could Be A Key Catalyst For Veeva Systems Stock (VEEV)

Veeva Systems recently hosted its Commercial Summit Europe in Copenhagen, where leaders from AstraZeneca, Bristol Myers Squibb, Roche and others shared how industry specific AI and Veeva's Commercial Cloud and Data Cloud tools support cust... Full story

Yahoo Finance • 6 days ago

Veeva Systems (VEEV) Heads Into Q3 Results As AI CRM Momentum Meets Fair Value Debate

Veeva Systems (VEEV) moves back into focus as investors look ahead to fiscal Q3 2027 results, with analysts projecting EPS of $1.68 and highlighting momentum in AI driven CRM adoption. Recent trading tells a story of rebuilding confidence... Full story

Yahoo Finance • 7 days ago

1 S&P 500 stock to consider right now and 2 we brush off

1 S&P 500 stock to consider right now and 2 we brush off The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are cre... Full story

Yahoo Finance • 13 days ago

Global Decentralized Clinical Trials Market Size, Share, Growth Trends, and Forecast 2026-2035 | Clinical Trials leave the Clinic as the Decentralized Model Heads for a $28.4bn Market

Company Logo New Report values decentralised clinical trials at $8bn in 2025, with hybrid models taking 54.1% and North America 44.2%, though data integrity and patchy regulation across regions still trouble IQVIA, Medidata, Medable and V... Full story

Yahoo Finance • 21 days ago

Veeva Systems (VEEV) Becomes Default Clinical Software Across A Major Research Partner

Veeva Systems (NYSE:VEEV) said IQVIA will adopt Veeva's core clinical applications as enterprise standards across all IQVIA studies. The expanded agreement covers Veeva Clinical Trial Management System, eTMF, Study Startup, and Site Connec... Full story

Yahoo Finance • 22 days ago

Global Life Sciences IT Market Opportunities and Strategies to 2035 | Capitalize on AI, Cloud and Bioinformatics as IQVIA, Oracle, Accenture, Veeva Systems and SAP Target $82.24B

Company Logo Boost ROI via AI/cloud and quantum tools, SaaS, integrated data ecosystems, digital channels, value-based contracts, targeted promotion, partnerships and user training. Dublin, Oct. 14, 2026 (GLOBE NEWSWIRE) -- "Life Science... Full story

Yahoo Finance • 22 days ago

Veeva Systems (VEEV) Increases Despite Market Slip: Here's What You Need to Know

In the latest trading session, Veeva Systems (VEEV) closed at $301.63, marking a +1.95% move from the previous day. The stock's performance was ahead of the S&P 500's daily loss of 0.02%. Meanwhile, the Dow lost 0.35%, and the Nasdaq, a te... Full story

Yahoo Finance • 24 days ago

Notable healthcare headlines for the week: Novavax, Moderna and Becton Dickinson in focus

Wall Street regained some momentum on Friday, after the AI trade came under pressure on Thursday. The S&P 500 (SP500 [https://seekingalpha.com/symbol/SP500#source=url_first_level%3Amarket-news%7Csection%3Amarket-news%7Csection_asset%3Aful... Full story

Yahoo Finance • 25 days ago

Veeva Systems’ (VEEV) Comeback Gets Jim Cramer Talking

During the October 7 episode of Mad Money, Jim Cramer discussed Veeva Systems Inc. (NYSE:VEEV) as an example of a software business that had recovered from fears about AI disruption, as he said: Take Veeva Systems, the best of its busines... Full story

Yahoo Finance • 27 days ago

Veeva (VEEV) Stock May Be 11% Below Fair Value After Biotech Adoption News

Veeva Systems has delivered a mixed share price story over recent years, which puts the focus firmly on whether the current market value lines up with the cash it can generate. With the stock now back near the spotlight after a solid multi... Full story

Yahoo Finance • 27 days ago

Veeva Summit to Showcase AI Innovations and the Leaders Transforming R&D and Quality

Eli Lilly and Company, Pfizer, Sanofi, UCB, and more share learnings speeding drug development, connecting trials, and modernizing quality and manufacturing PLEASANTON, Calif., Oct. 8, 2026 /PRNewswire/ -- At Veeva R&D and Quality Summit... Full story

Yahoo Finance • 28 days ago

Jim Cramer Has Reservations About One of These Software Comebacks

On October 1, Jim Cramer discussed Veeva Systems Inc. (NYSE:VEEV) while reviewing the third-quarter recovery in software stocks. He mentioned that he prefers Salesforce, Inc. (NYSE:CRM), as he said: On the first day of a brand new quarter... Full story

Yahoo Finance • last month

13 High-Conviction & Catalyst-Driven Long Ideas for 4Q 2026

Investing.com -- Wells Fargo Securities named 13 stocks across seven sectors as its fourth-quarter 2026 long ideas, citing company-specific catalysts that could drive significant gains. Before you buy NVIDIA: our AI model's stock picks ar... Full story

Yahoo Finance • last month

How Investors Are Reacting To Veeva Systems (VEEV) Expanding Agentic AI And Winning New Pharma Clients

In recent days, Veeva Systems has rolled out new AI-powered tools such as Veeva Study Builder Agent and Veeva Falcon Router, while announcing major customer wins including Oxford Biomedica adopting Veeva Quality Cloud and Amgen planning a... Full story

Yahoo Finance • last month

New Veeva Study Builder Agent to Configure Clinical Studies in as Little as One Day

Standards-first agent delivers faster and more consistent EDC and DQS builds PLEASANTON, Calif., Sept. 24, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva Study Builder Agent, a new AI solution that configures Veeva... Full story

Yahoo Finance • last month

Quality Management System Software Market Forecasts Growth from $11.73B (2026) to $20.43B by 2031, Profiling Veeva Systems, Siemens, PTC, SAP, Oracle & 15 Others

Company Logo The global Quality Management System (QMS) software market is projected to grow from USD 11.73 billion in 2026 to USD 20.43 billion by 2031, at an 11.7% CAGR. Growth is driven by cloud-based QMS platforms, AI-powered quality... Full story

Yahoo Finance • last month

Vault CRM Extends Market Leadershipas Another Top 20 Biopharma Chooses Veeva

With 190 live customers and 14 top 20 biopharma commitments, Vault CRM is the fastest path to AI PLEASANTON, Calif., Sept. 23, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced a new top 20 biopharma commitment, adding to r... Full story

Yahoo Finance • last month

eClinical Solutions Market by Product, Application, Trial Phase, End User, Regulatory, AI, Growth, Market Size - Forecast to 2030

Company Logo The global eClinical solutions market is projected to grow from USD 13.18 billion in 2025 to USD 25.22 billion by 2030, registering a 13.9% CAGR. Growth is driven by rising clinical trial costs, regulatory requirements, R&D i... Full story

Yahoo Finance • last month

Pharmacovigilance Software Market Size, Share & Trends Analysis - Global Opportunity Analysis and Industry Forecast (2026-2036)

Company Logo The global pharmacovigilance software market is projected to grow from USD 4.5 billion in 2026 to USD 12.7 billion by 2036, at a 10.9% CAGR. Growth is driven by stricter drug safety regulations, expanding clinical trials, ris... Full story